Cardioprotective pathways during reperfusion: Focus on redox signaling and other modalities of cell signaling

Antioxidants and Redox Signaling

Volumn 14, Issue 5, 2011, Pages 833-850

  Pagliaro, Pasquale ^a   Moro, Francesca ^a   Tullio, Francesca ^a   Perrelli, Maria Giulia ^a   Penna, Claudia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HYDROGEN SULFIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

CELL DEATH; GLYCOSYLATION; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 79551656099     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3245     Document Type: Review

References (215)

1. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP, Condorelli M, and Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87: 2056-2066, 1991.
2. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, and Chiariello M. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268: 18532-18541, 1993.
3. Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS, and DANAMI-2 Investigators. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: Rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 146: 234-241, 2003.
4. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194-197, 2005.
5. Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S, Huang M-H, Uretsky BF, Perez-Polo JR, and Birnbaum Y. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol 290: H1960-H1968, 2006.
6. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, and Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662, 2005.
7. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, and Ping P. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
8. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: Enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90: 390-397, 2002.
9. Baines CP. The mitochondrial permeability transition pore as a target of cardioprotective signaling. Am J Physiol Heart Circ Physiol 293: H903-H904, 2007.
10. Beauchamp P, Richard V, Tamion F, Lallemand F, Lebreton JP, Vaudry H, Daveau M, and Thuillez C. Protective effects of preconditioning in cultured rat endothelial cells: Effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation 100: 541-546, 1999.
11. Beckman JS, Beckman TW, Chen J, Marshall PH, and Freeman BA. Apparent hydroxyl radical production by peroxylnitrites: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
12. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol Cell Physiol 271: C1424-1437, 1996.
13. Benhar M, Forrester MT, and Stamler JS. Protein denitrosylation: Enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10: 721-732, 2009.
14. Boengler K, Heusch G, and Schulz R. Mitochondria in postconditioning. Antioxid Redox Signal 14: 863-880, 2011.
15. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, and Schulz R. The myocardial JAK=STAT pathway: From protection to failure. Pharmacol Ther 120: 172-185, 2008.
16. Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, and Schulz R. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol 104: 141-147, 2009.
17. Borutaite V, Jekabsone A, Morkuniene R, and Brown GC. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol. 35: 339-341, 2003.
18. Bouwman RA, Musters RJP, van Beek-Harmsen Brechje J, de Lange Jaap J, and Boer C. Reactive oxygen species precede protein dinase C-[delta] activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology 100: 506-514, 2004.
19. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darley-Usmar VM, and Anderson PG. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 275:20474-20479, 2000.
20. Burnett G and Kennedy EP. The enzymatic phosphorylation of proteins. J Biol Chem 211: 969-980, 1954.
21. Burwell LS and Brookes PS. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemiareperfusion injury. Antioxid Redox Signal 10: 579-599, 2008.
22. Camara AK, Lesnefsky EJ, and Stowe DF. Potential therapeutic benefits of strategies directed to mitochondria. Antiox Redox Signal 13: 279-347, 2010.
23. Champattanachai V, Marchase RB, and Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemiareperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294: C1509-C1520, 2008.
24. Chen K, Craige SE, and Keaney JF Jr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal 11: 2467-2480, 2009.
25. Chen L, Hahn H, Wu G, Chen C-H, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW II, and Mochly-Rosen D Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
26. Chen Z, Li T, and Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 145: 287-294, 2008.
27. Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, and Rasola A. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One 3:e1852, 2008.
28. Churchill EN and Mochly-Rosen D. The roles of PKCd and e isoenzymes in the regulation of myocardial ischaemia= reperfusion injury. Biochem Soc Trans 35: 1040-1042, 2007.
29. Cohen MV and Downey JM Ischemic postconditioning: From receptor to end-effector. Antioxid Redox Signal 14: 821-831, 2011.
30. Cohen MV, Yang XM, and Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115: 1895-1903, 2007.
31. Crisafulli A, Melis F, Tocco F, Santoboni UM, Lai C, Angioy G, Lorrai L, Pittau G, Concu A, and Pagliaro P. Exerciseinduced and nitroglycerin-induced myocardial preconditioning improves hemodynamics in patients with angina. Am J Physiol Heart Circ Physiol 287: H235-242, 2004.
32. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249, 1999.
33. Daiber A. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta 1797: 897-906, 2010.
34. Daiber A, Schildknecht S, Müller J, Kamuf J, Bachschmid MM, and Ullrich V. Chemical model systems for cellular nitros(yl)ation reactions. Free Radic Biol Med 47: 458-467, 2009.
35. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-474, 2008.
36. Das M, Parker JE, and Halestrap AP. Matrix volume measurements challenge the existence of diazoxide= glibencamide-sensitive KATP channels in rat mitochondria. J Physiol 547: 893-902, 2003.
37. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36: 181-199, 2000.
38. Di Lisa F and Bernardi P. Mitochondria and ischemiareperfusion injury of the heart: fixing a hole. Cardiovasc Res 70: 191-199, 2006.
39. Di Lisa F, Canton M, Carpi A, Kaludercic N, Menabò R, Menazza S, and Semenzato M. Mitochondrial injury and protection in ischemic pre-and post-conditioning. Antioxid Redox Signal 14: 881-891, 2011.
40. Di Lisa F, Canton M, Menabò R, Kaludercic N, and Bernardi P. Mitochondria and cardioprotection. Heart Fail Rev 12: 249-260, 2007.
41. Di Lisa F, Kaludercic N, Carpi A, Menabò R, and Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: The relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol 104: 131-139, 2009.
42. Downey JM and Cohen MV. O-linked beta-Nacetylglucosamine: A new piece of the cardioprotection puzzle? Circ Res 104: 7-8, 2009.
43. Downey JM and Cohen MV. A really radical observation-a comment on Penna et al. in Basic Res Cardiol (2006) 101:180-189.
44. Basic Res Cardiol. 101: 190-191, 2006.
45. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, and Parker JD. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27: 1955-1959, 2007.
46. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, and Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97: 12222-12226, 2000.
47. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J, and Gunter TE. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 284: 9692-9699, 2009.
48. Elrod J W, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabó C, Kimura H, Chow CW, and Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007.
49. Fang JK, Prabu SK, Sepuri NB, Raza H, Anandatheerthavarada HK, Galati D, Spear J, and Avadhani NG. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia= reperfusion. FEBS Lett 581: 1302-1310, 2007.
50. Fantinelli JC and Mosca SM. Cardioprotective effects of a non-alcoholic extract of red wine during ischaemia and reperfusion in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34: 166-169, 2007.
51. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, and Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 103: 987-995, 2005.
52. Feng J, Zhu M, Schaub MC, Gehrig P, Roschitzki B, Lucchinetti E, and Zaugg M. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 80: 20-29, 2008.
53. Ferdinandy P and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138: 532-543, 2003.
54. Ferdinandy P, Schulz R, and Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia= reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458, 2007.
55. Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, Kim J, Takashima S, Tsukamoto O, Minamino T, Shinozaki Y, Tomoike H, Hori M, and Kitakaze M. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 292: H2004-H2008, 2007.
56. Fukuto JM, Jackson MI, Kaludercic N, and Paolocci N. Examining nitroxyl in biological systems. Methods Enzymol 440: 411-431, 2008.
57. Galagudza M, Kurapeev D, Minasian S, Valen G, and Vaage J. Ischemic postconditioning: Brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiothorac Surg 25: 1006-1010, 2004.
58. Garlid KD, Costa AD, Quinlan CL, Pierre SV, and Dos Santos P. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 46: 858-866, 2009.
59. Gateau-Roesch O, Argaud L, and Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 70: 264-273, 2006.
60. Gomez L, Li B, Mewton N, Sanchez I, Piot C, Elbaz M, and Ovize M. Inhibition of mitochondrial permeability transition pore opening: Translation to patients. Cardiovasc Res 83: 226-233, 2009.
61. Gomez L, Thibault HB, Gharib A, Dumont JM, Vuagniaux G, Scalfaro P, Derumeaux G, and Ovize M. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 293: H1654-H1661, 2007.
62. Gong P, Hu B, and Cederbaum AI. Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch Biochem Biophys 432: 252-260, 2004.
63. Gottlieb RA, Finley KD, and Mentzer RM Jr. Cardioprotection requires taking out the trash. Basic Res Cardiol 104: 169-180, 2009.
64. Grech ED and Ramsdale DR. Termination of reperfusion arrhythmia by coronary artery occlusion. Br Heart J 72: 94-95, 1994.
65. Griffiths EJ and Halestrap AP. Mitochondrial nonspecific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307: 93-98, 1995.
66. Gross ER and Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70: 212-221, 2006.
67. HalestrapAP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans 34: 232-237, 2006.
68. Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, and Korsmeyer SJ. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell 3: 413-422, 1999.
69. Hausenloy DJ and Yellon DM. Preconditioning and postconditioning: New strategies for cardioprotection. Diabetes Obes Metab 10: 451-459, 2008.
70. Hausenloy DJ and Yellon DM. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35: 339-341, 2003.
71. Hausenloy DJ, Lecour S, and Yellon DM. Reperfusion Injury Salvage Kinase and Survivor Activating Factor Enhancement prosurvival signaling pathways in ischaemic postconditioning: Two sides of the same coin. Antioxid Redox Signal 14: 893-907, 2011.
72. Hausenloy DJ, Mocanu MM, and Yellon DM. Cross-talk between the survival kinases during early reperfusion: Its contribution to ischemic preconditioning. Cardiovasc Res 63: 305-312, 2004.
73. Hausenloy DJ, Ong SB, and Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104: 189-202, 2009.
74. Hausenloy DJ, Wynne AM, and Yellon DM. Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol 102: 445-452, 2007.
75. Helling S, Vogt S, Rhiel A, Ramzan R, Wen L, Marcus K, and Kadenbach B. Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol Cell Proteomics 7: 1714-1724, 2008.
76. Hess DT, Matsumoto A, Nudelman R, and Stamler JS. S-nitrosylation: Spectrum and specificity. Nat Cell Biol 3: E46-E49, 2001.
77. Heusch G. No risk, no. . .cardioprotection? A critical perspective. Cardiovasc Res 84: 173-175, 2009.
78. Heusch G. Postconditioning: Old wine in a new bottle? J Am Coll Cardiol 44: 1111-1112, 2004.
79. Horbinski C and Chu CT. Kinase signaling cascades in the mitochondrion: A matter of life or death. Free Radic Biol Med 38: 2-11, 2005.
80. Hurd TR, Costa NJ, Dahm CC, Beer SM, Brown SE, Filipovska A, and Murphy MP. Glutathionylation of mitochondrial proteins. Antioxid Redox Signal 7: 999-1010, 2005.
81. Hurd TR, Prime TA, Harbour ME, Lilley KS, and Murphy MP. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: Implications for mitochondrial redox signaling. J Biol Chem 282: 22040-22051, 2007.
82. Iliodromitis EK, Andreadou I, Prokovas E, Zoga A, Farmakis D, Fotopoulou T, Ioannidis K, Paraskevaidis IA, and Kremastinos DT. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: Possible role of oxidative=nitrosative stress attenuation. Basic Res Cardiol 105: 193-203, 2010.
83. Iliodromitis EK, Downey JM, Heusch G, and Kremastinos DT. What is the optimal postconditioning algorithm? J Cardiovasc Pharmacol Ther 14: 269-273, 2009.
84. Inserte J, Barba I, Hernando V, Abellán A, Ruiz-Meana M, Rodr?́guez-Sinovas A, and Garcia-Dorado D. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res 77: 782-790, 2008.
85. Inserte J, Ruiz-Meana M, Rodr?́guez-Sinovas A, Barba I, and Garcia-Dorado D. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. Antioxid Redox Signal 14: 923-939, 2011.
86. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 305: 776-783, 2003.
87. Ivanès F, Rioufol G, Piot C, and Ovize M. Postconditioning in acute myocardial infarction patients. Antioxid Redox Signal 14: 811-820, 2011.
88. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, and van der Vliet A. Redox-based regulation of signal transduction: Principles, pitfalls, and promises. Free Radic Biol Med 45: 1-17, 2008.
89. Jensen ON. Interpreting the protein language using proteomics. Nat Rev Mol Cell Biol 7: 391-403, 2006.
90. Ji Y, Pang QF, Xu G, Wang L, Wang JK, and Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 587: 1-7, 2008.
91. Jiang B, Tang G, Cao K, Wu L, and Wang R. Molecular mechanism for H2S-induced activation of KATP channels. Antioxid Redox Signal 12: 1167-1178, 2010.
92. Jin ZQ, Karliner JS, and Vessey DA. Ischaemic postconditioning protects isolated mouse hearts against ischaemia= reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res 79: 134-140, 2008.
93. Jones SP and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40: 16-23, 2006.
94. Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, Hart GW, and Marban E. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117: 1172-1182, 2008.
95. Kane LA and Van Eyk JE. Post-translational modifications of ATP synthase in the heart: Biology and function. J Bioenerg Biomembr 41: 145-150, 2009.
96. Kim YM, Talanian RV, and Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272: 31138-31148, 1997.
97. Kloner RA, Dow J, and Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemiareperfusion. J Cardiovasc Pharmacol Ther 11: 55-63, 2006.
98. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, and Wallace DC. The ADP=ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461-465, 2004.
99. Korichneva I. Zinc dynamics in the myocardial redox signaling network. Antioxid Redox Signal 8: 1707-1721, 2006.
100. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, Csont T, and Ferdinandy P. Cholesterol dietinduced hyperlipidemia impairs the cardioprotective effect of postconditioning: Role of peroxynitrite. Am J Physiol Heart Circ Physiol 297: H1729-H1735, 2009.
101. Kusuoka H and Marban E. Cellular mechanisms of myocardial stunning. Annu Rev Physiol 54: 243-256, 1992.
102. Laczy B, Bradford GH, Wang K, Paterson AJ, White CR, Xing D, Chen Y-F, Darley-Usmar V, Oparil S, and Chatham JC. Proteine O-GlcNAcylation: A new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol 296: H13-H28, 2009.
103. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol 47: 32-40, 2009.
104. Lefer DJ, Nichols CG, and Coetzee WA. Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia=reperfusion injury. Trends Cardiovasc Med 19: 61-67, 2009.
105. Lewandrowski U, Sickmann A, Cesaro L, Brunati AM, Toninello A, and Salvi M. Identification of new tyrosine phosphorylated proteins in rat brain mitochondria. FEBS Lett 582: 1104-1110, 2008.
106. Lim SY, Davidson SM, Hausenloy DJ, and Yellon DM. Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75: 530-535, 2007.
107. Liu J, Marchase RB, and Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia=reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 42: 177-185, 2007.
108. Liu J, Marchase RB, and Chatham JC. Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 293: H1391-H1399, 2007.
109. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, and Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314: 877-880, 1996.
110. Ludman AJ, Yellon DM, and Hausenloy DJ. Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 3: 35-38, 2010.
111. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
112. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, and Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide. Biochim Biophys Acta 1787: 864-872, 2009.
113. Mancardi D, Ridnour LA, Thomas DD, Katori T, Tocchetti CG, Espey MG, Miranda KM, Paolocci N, and Wink DA. The chemical dynamics of NO and reactive nitrogen oxides: A practical guide. Curr Mol Med 4: 723-740, 2004.
114. Manintveld OC, Hekkert ML, van der Ploeg NT, Verdouw PD, and Duncker DJ. Interaction between pre-and postconditioning in the in vivo rat heart. Exp Biol Med (Maywood) 234: 1345-1354, 2009.
115. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, and Stamler JS. Fas-induced caspase denitrosylation. Science 284: 651-654, 1999.
116. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, and Gaston B. S-Nitrosylation of mitochondrial caspases. J Cell Biol 154: 1111-1116, 2001.
117. Marczin N, El-Habashi N, Hoare GS, Bundy RE, and Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: Therapeutic potential and basic mechanisms. Arch Biochem Biophys 420: 222-236, 2003.
118. Mitchell DA and Marletta MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol 1: 154-158, 2005.
119. Mochly-Rosen D and Gordon AS. Anchoring proteins for protein kinase C: A means for isozyme selectivity. FASEB J 12: 35-42, 1998.
120. Moncada S and Erusalimsky JD. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 3: 214-220, 2002.
121. Morrison DA, Berman M, El-Amin O, McLaughlin RT, and Bates ER. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI). Minerva Cardioangiol 55: 593-623, 2007.
122. Murphy E and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008.
123. Murphy E and Steenbergen C. Preconditioning: The mitochondrial connection. Annu Rev Physiol 69: 51-67, 2007.
124. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
125. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, and Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal 2:ra72, 2009.
126. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, and Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 132: 78-83, 1996.
127. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, and Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652-658, 2005.
128. Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H, Jaleel N, Chua BH, Hewett TE, Robbins J, Houser SR, and Molkentin JD. Ca2 and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 117: 2431-2444, 2007.
129. Ngoh GA and Jones SP. New insights into metabolic signaling and cell survival: The role of beta-O-linkage of Nacetylglucosamine. J Pharmacol Exp Ther 327: 602-609, 2008.
130. Ngoh GA, Facundo HT, Hamid T, Dillmann W, Zachara NE, and Jones SP. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia=reoxygenation injury. Circ Res 104: 41-49, 2009.
131. Ngoh GA, Watson LJ, Facundo HT, Dillmann W, and Jones SP. Non-canonical glycosyltransferase modulates posthypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 45: 313-325, 2008.
132. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, and Marber MS. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 103: 307-314, 2008.
133. Ogbi M and Johnson JA. Protein kinase C epsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem J 393: 191-199, 2006.
134. Onody A, Csonka C, Giricz Z, and Ferdinandy P. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58: 663-670, 2003.
135. Otani H. Ischemic preconditioning: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 207-247, 2008.
136. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
137. Pagliarini DJ and Dixon JE. Mitochondrial modulation: Reversible phosphorylation takes center stage? Trends Biochem Sci 31: 26-34, 2006.
138. Pagliaro P. Differential biological effects of products of nitric oxide (NO) synthase: It is not enough to say NO. Life Sci 73: 2137-2149, 2003.
139. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, and Fukuto JM. The pharmacology of nitroxyl (HNO=NO-) and its therapeutic potential: Not just the Janus face of NO. Pharmacol Ther 113: 442-458, 2007.
140. Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, Losano G, and Pagliaro P. Post-conditioning reduces infarct size in the isolated rat heart: Role of coronary flow and pressure and the nitric oxide=cGMP pathway. Basic Res Cardiol 101: 168-179, 2006.
141. Penna C, Mancardi D, Raimondo S, Geuna S, and Pagliaro P. The paradigm of postconditioning to protect the heart. J Cell Mol Med 12: 435-458, 2008.
142. Penna C, Mancardi D, Rastaldo R, Losano G, and Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 75: 168-177, 2007.
143. Penna C, Mancardi D, Rastaldo R, and Pagliaro P. Cardioprotection: A radical view free radicals in pre and postconditioning. Biochim Biophys Acta 1787: 781-793, 2009.
144. Penna C, Mancardi D, Tullio F, and Pagliaro P. Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection, J Surg Res 153: 231-238, 2009.
145. Penna C, Mancardi D, Tullio F, and Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol 103: 368-377, 2008.
146. Penna C, Pagliaro P, Rastaldo R, Di Pancrazio F, Lippe G, Gattullo D, Mancardi D, Samaja M, Losano G, and Mavelli I. F0F1 ATP synthase activity is differently modulated by coronary reactive hyperemia before and after ischemic preconditioning in the goat. Am J Physiol Heart Circ Physiol 287: H2192-H1200, 2004.
147. Penna C, Perrelli MG, Raimondo S, Tullio F, Merlino A, Moro F, Geuna S, Mancardi D, and Pagliaro P. Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta 1787: 794-801, 2009.
148. Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, Losano G, and Pagliaro P. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K channel and protein kinase C activation. Basic Res Cardiol 101: 180-189, 2006.
149. Penna C, Tullio F, Merlino A, Moro F, Raimondo S, Rastaldo R, Perrelli MG, Mancardi D, and Pagliaro P. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol 104: 390-402, 2009.
150. Penna C, Tullio F, Moro F, Folino A, Merlino A, and Pagliaro P. Effects of a protocol of ischemic postconditioning and=or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol 105: 181-192, 2010.
151. Penna C, Tullio F, Perrelli M, Moro F, Parisella ML, Merlino A, and Pagliaro P. Involvement of catalase (CAT), superoxide dismutase (SOD), reactive species (RNS), and protein nitrosylation in postconditioning (PostC) cardioprotection. Acta Physiol 197: p93 (Abstract), 2009.
152. Piper HM, Meuter K, and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75: S644-S648, 2003.
153. Poole LB, Karplus PA, and Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44: 325-347, 2004.
154. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, and Avadhani NG. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 281: 2061-2070, 2006.
155. Prime TA, Blaikie FH, Evans C, Nadtochiy SM, James AM, Dahm CC, Vitturi DA, Patel RP, Hiley CR, Abakumova I, Requejo R, Chouchani ET, Hurd TR, Garvey JF, Taylor CT, Brookes PS, Smith RAJ, and Murphy MP. A mitochondriatargeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci U S A 106:10764-10769, 2009.
156. Przyklenk K, Maynard M, Greiner DL, and Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 14: 781-790, 2011.
157. Przyklenk K. Lethal myocardial reperfusion injury: The opinions of good men. J Thrombosis Thrombolysis 4: 37-39, 1997.
158. Raat NJ, Shiva S, and Gladwin MT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion Adv Drug Deliv Rev. 61: 339-350, 2009.
159. Radi R, Cassina A, Hodara R, Quijano C and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol and Med 33: 1451-1464, 2002.
160. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250, 1991.
161. Rajamani U and Essop MF. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299: C139-C147, 2010.
162. Rathore R, Zheng YM, Niu CF, Liu QH, Korde A, Ho YS, and Wang YX. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 45: 1223-1231, 2008.
163. Reffelmann T and Kloner RA. The "no-reflow" phenomenon: Basic science and clinical correlates. Heart 87: 162-168, 2002.
164. Reimer KA, Murry CE, and Richard VJ. The role of neutrophils and free radicals in the ischemic-reperfused heart: Why the confusion and controversy? J Mol Cell Cardiol 21: 1225-1239, 1989.
165. Ridnour LA, Thomas DD, Mancardi D, Donzelli S, Paolocci N, Pagliaro P, Miranda KM, MC Krishna, Fukuto J, Grisham MB, Mitchell JB, Espey MG, and Wink DA. Antioxidant properties of nitric oxide in cellular physiological and pathophysiological mechanisms. The implications of biological balance between NO and oxidative stress. Curr Med Chem-Anti-Inflamm Anti-Allergy Agents 3: 181-188, 2004.
166. Ronson RS, Nakamura M, and Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44: 47-59, 1999.
167. Sabri A, Byron KL, Samarel AM, Bell J, and Lucchesi PA. Hydrogen peroxide activates mitogen-activated protein kinases and Na-H exchange in neonatal rat cardiac myocytes. Circ Res 82: 1053-1062, 1998.
168. Saini HK, Machackova J and Dhalla NS. Role of reactive oxygen species in ischemic preconditioning of subcellular organelles in the heart. Antioxid Redox Signal 6: 393-404, 2004.
169. Sasaki N, Sato T, Ohler A, ORourke B, and Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101: 439-445, 2000.
170. Schulz R, Kelm M, and Heusch G. Nitric oxide in myocardial ischemia=reperfusion injury. Cardiovasc Res 61: 402-413, 2004.
171. Siegmund B, Schluter KD, and Piper HM. Calcium and the oxygen paradox. Cardiovasc Res 27: 1778-1783, 1993.
172. Simon DI, Mullins ME, Jia L, Gaston B, Singel DJ, and Stamler JS. Polynitrosylated proteins: Characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A 93: 4736-4741, 1996.
173. Sivaraman V, Mudalagiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, and Yellon DM. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 102: 453-459, 2007.
174. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, and Heusch G. Ischemic postconditioning in pigs no causal role for risk activation. Circ Res 104: 15-18, 2009.
175. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, and Heusch G. Ischemic postconditioning: Experimental models and protocol algorithms. Basic Res Cardiol 104: 469-483, 2009.
176. Smith FD, Langeberg LK, and Scott JD. The wheres and whens of kinase anchoring. Trends Biochem Sci 31: 316-323, 2006.
177. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, LHuillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, and Ovize M. Postconditioning the human heart. Circulation 112: 2143-2148, 2005.
178. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, and Bolli R. Delayed adaptation of the heart to stress: Late preconditioning. Stroke 35: 2676-2679, 2004.
179. Sun J, Morgan M, Shen RF, Steenbergen C, and Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 101: 1155-1163, 2007.
180. Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, and Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2 channel a1 subunit and reduced ischemia=reperfusion injury. Circ Res 98: 403-411, 2006.
181. Sun J, Steenbergen C, and Murphy E. S-nitrosylation: NOrelated redox signaling to protect against oxidative stress. Antioxid Redox Signal 8: 1693-1705, 2006.
182. Takagi H, Matsui Y, and Sadoshima J. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal 9: 1373-1381, 2007.
183. Tota B, Angelone T, Mancardi D and Cerra MC. Hypoxia and anoxia tolerance of vertebrate hearts: An evolutionary perspective. Antioxid Redox Signal 14: 851-862, 2011.
184. Tritto I and Ambrosio G. Role of oxidants in the signaling pathway of preconditioning. Antioxid Redox Signal 3: 3-10, 2001.
185. Tritto I, Dandrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, and Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80: 743-748, 1997.
186. Tsang A, Hausenloy DJ, Mocanu MM, and Yellon DM. Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95: 230-232, 2004.
187. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, and Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterization. Life Sci 81: 1223-1227, 2007.
188. Turko IV and Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 54: 619-634, 2002.
189. Ullrich V and Kissner R. Redox signaling: bioinorganic chemistry at its best. J Inorg Biochem 100: 2079-2086, 2006.
190. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, OCollins V, and Macleod MR. Can animal models of disease reliably inform human studies? PLoS Med 7: e1000245, 2010.
191. Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, and Przyklenk K. The multidimensional physiological responses to postconditioning. Antioxid Redox Signal 14: 791-810, 2011.
192. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, and Kerendi F. Postconditioning-A new link in natures armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100: 295-310, 2005.
193. Wang HC, Zhang HF, Guo WY, Su H, Zhang KR, Li QX, Yan W, Ma XL, Lopez BL, Christopher TA, and Gao F. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: Role of peroxynitrite formation. Apoptosis 11: 1453-1460, 2006.
194. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5: 493-501, 2003.
195. Wang Z, Gucek M, and Hart GW. Cross-talk between GlcNAcylation and phosphorylation: Site-specific phosphorylation dynamics in response to globally elevated OGlcNAc. Proc Natl Acad Sci USA 105: 13793-13798, 2008.
196. Wang Z, Pandey A, and Hart GW. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics 6: 1365-1379, 2007.
197. Weiss JN, Korge P, Honda HM, and Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93: 292-301, 2003.
198. Wells L, Vosseller K, and Hart GW. Glycosylation of nucleocytoplasmic proteins: Signal transduction and OGlcNAc. Science 291: 2376-2378, 2001.
199. Wink DA, Miranda KM, Katori T, Mancardi D, Thomas DD, Ridnour L, Espey MG, Feelisch M, Colton CA, Fukuto JM, Pagliaro P, Kass DA, and Paolocci N. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: A novel redox paradigm. Am J Physiol Heart Circ Physiol 285: H2264-H2276, 2003.
200. Wong W and Scott JD. AKAP signalling complexes: Focal points in space and time. Nat Rev Mol Cell Biol 5: 959-970, 2004.
201. Xi L, Das A, Zhao ZQ, Merino VF, Bader M, and Kukreja RC. Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation 118: S32-S37, 2008.
202. Yellon DM and Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 83: 1113-1151, 2003.
203. Yellon DM and Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
204. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, and Bian JS. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 295: H1330-H1340, 2008.
205. Zhang YY, Xu AM, Nomen M, Walsh M, Keaney JF Jr, and Loscalzo J. Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity. J Biol Chem 271: 14271-14279, 1996.
206. Zhao ZQ and Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55; 438-455, 2002.
207. Zhao ZQ and Vinten-Johansen J. Postconditioning: Reduction of reperfusion-induced injury. Cardiovasc Res 70: 200-211, 2006.
208. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.
209. Erratum in: Am J Physiol Heart Circ Physiol 286; H477, 2004.
210. Zhao ZQ. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol 4: 159-165, 2004.
211. Zorov DB, Filburn CR, Klotz LO, Zweier JL, and Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192: 1001-1014, 2000.
212. Zorov DB, Juhaszova M, and Sollott SJ. Mitochondrial ROS-induced ROS release: An update and review. Biochim Biophys Acta 1757: 509-517, 2006.
213. Zou M, Martin C, and Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 378: 707-713, 1997.
214. Zou MH, Shi C, and Cohen RA. Oxidation of the zincthiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.
215. Zweier JL, Samouilov A, and Kuppusamy P. Nonenzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1411: 250-262, 1999.